HIV drug resistance analysis tool based on process algebra

被引:0
|
作者
de Araujo, Luciano Vieira [1 ]
Sabino, Ester C. [2 ]
Ferreira, Joao Eduardo [3 ]
机构
[1] Univ Sao Paulo, Dept Bioinformat, Rua Matao 1010, BR-05508009 Sao Paulo, Brazil
[2] Univ Sao Paulo, Fundacao Prosangue, Sao Paulo, Brazil
[3] Univ Sao Paulo, Dept Comp Sci, Sao Paulo, Brazil
关键词
Process Algebra; Drug Resistance; HIV; NPDL; Mutation Analysis; Genotypic Drug Resistance Testing;
D O I
暂无
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
The increasing number of drugs used in HIV patient treatment and the mutations associated with drug resistance make the inference of drug resistance a complex task that demands computational systems. Furthermore, the software development/update can generate an extra level of complexity in the process drug resistance analysis. An alternative to handle the complexity of drug resistance and software development is to use a formal representation of involved processes, such as process algebra. This allows mathematical reasoning about the analysis process, a precise description of system behavior, more advanced computational approaches, as concurrent/parallel execution and (semi) automatic software development. The first contribution of this research is a mapping of drug resistance algorithms rules into expressions of process algebra which facilitates the computational manipulation of theses rules. The second contribution is the HIVdag (HIV Drug Analysis Generator) system. This software supports the definition, generation and analyses of genotypic drug resistance tests based on process algebra expressions. Therefore, the users can easily create/update their own drug resistance algorithms any time and independent of software development.
引用
收藏
页码:1358 / 1363
页数:6
相关论文
共 50 条
  • [31] HIV drug resistance testing
    Bartlett, JG
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1999, 8 (05) : 223 - 223
  • [32] The pharmacology of HIV drug resistance
    Zdanowicz, Martin M.
    AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, 2006, 70 (05)
  • [33] HIV DRUG-RESISTANCE
    RICHMAN, DD
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (06) : 1065 - 1071
  • [34] HIV drug resistance on the rise
    不详
    LABORATORY MEDICINE, 1999, 30 (12) : 764 - 765
  • [35] Bayesian Analysis of Complex Interacting Mutations in HIV Drug Resistance and Cross-Resistance
    Kozyryev, Ivan
    Zhang, Jing
    ADVANCE IN STRUCTURAL BIOINFORMATICS, 2015, 827 : 367 - 383
  • [36] QuasiFlow: a Nextflow pipeline for analysis of NGS-based HIV-1 drug resistance data
    Ssekagiri, Alfred
    Jjingo, Daudi
    Lujumba, Ibra
    Bbosa, Nicholas
    Bugembe, Daniel L.
    Kateete, David P.
    Jordan, I. King
    Kaleebu, Pontiano
    Ssemwanga, Deogratius
    Lengauer, Thomas
    BIOINFORMATICS ADVANCES, 2022, 2 (01):
  • [37] Using relation algebra for the analysis of Petri nets in a CASE tool based approach
    Fronk, A
    PROCEEDINGS OF THE SECOND INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING AND FORMAL METHODS, 2004, : 396 - 405
  • [38] MinVar: A rapid and versatile tool for HIV-1 drug resistance genotyping by deep sequencing
    Huber, Michael
    Metzner, Karin J.
    Geissberger, Fabienne D.
    Shah, Cyril
    Leemann, Christine
    Klimkait, Thomas
    Boni, Jurg
    Trkola, Alexandra
    Zagordi, Osvaldo
    JOURNAL OF VIROLOGICAL METHODS, 2017, 240 : 7 - 13
  • [39] Next generation sequencing: a game-changing tool for HIV drug resistance testing in Thailand
    Chantratita, Wasun
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S14 - S14
  • [40] Automated sequence analysis and editing software for HIV drug resistance testing
    Struck, Daniel
    Wallis, Carole L.
    Denisov, Gennady
    Lambert, Christine
    Servais, Jean-Yves
    Viana, Raquel V.
    Letsoalo, Esrom
    Bronze, Michelle
    Aitken, Sue C.
    Schuurman, Rob
    Stevens, Wendy
    Schmit, Jean Claude
    de Wit, Tobias Rinke
    Bercoff, Danielle Perez
    JOURNAL OF CLINICAL VIROLOGY, 2012, 54 (01) : 30 - 35